Home › Sarcoma ng Malambot na Tisyu
Pag-aaral pangklinika para sa Sarcoma ng Malambot na Tisyu na nagre-recruit sa U.S.
136 pag-aaral para sa Sarcoma ng Malambot na Tisyu ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX32 pag-aaral
- New York City, NY20 pag-aaral
- Boston, MA17 pag-aaral
- Los Angeles, CA13 pag-aaral
- St. Louis, MO12 pag-aaral
- Columbus, OH12 pag-aaral
- Washington, DC11 pag-aaral
- Memphis, TN10 pag-aaral
- Philadelphia, PA9 pag-aaral
- Aurora, CO8 pag-aaral
- Nashville, TN8 pag-aaral
- Durham, NC8 pag-aaral
- Queens, NY8 pag-aaral
- Rochester, MN7 pag-aaral
- Dallas, TX7 pag-aaral
- Atlanta, GA7 pag-aaral
- Chicago, IL7 pag-aaral
- Grand Rapids, MI7 pag-aaral
- Baldwin Park, CA7 pag-aaral
- Greenburgh, NY7 pag-aaral
- Santa Monica, CA7 pag-aaral
- Mountain View, CA6 pag-aaral
- Miami, FL6 pag-aaral
- Orange, CA6 pag-aaral
- Staten Island, NY6 pag-aaral
- New Rochelle, NY6 pag-aaral
- Edison, NJ6 pag-aaral
- East Norwalk, CT6 pag-aaral
- Arlington, VA5 pag-aaral
- Baltimore, MD5 pag-aaral
- Cleveland, OH5 pag-aaral
- San Francisco, CA5 pag-aaral
- Birmingham, AL5 pag-aaral
- Pittsburgh, PA5 pag-aaral
- Cincinnati, OH4 pag-aaral
- Jacksonville, FL4 pag-aaral
- Omaha, NE4 pag-aaral
- Charlotte, NC3 pag-aaral
- Tampa, FL3 pag-aaral
- The Bronx, NY3 pag-aaral
Ayos sa estado
- Alabama6 pag-aaral
- Arizona5 pag-aaral
- California39 pag-aaral
- Colorado11 pag-aaral
- Connecticut4 pag-aaral
- District of Columbia6 pag-aaral
- Florida20 pag-aaral
- Georgia8 pag-aaral
- Illinois9 pag-aaral
- Iowa3 pag-aaral
- Kansas3 pag-aaral
- Maryland10 pag-aaral
- Massachusetts18 pag-aaral
- Michigan9 pag-aaral
- Minnesota10 pag-aaral
- Missouri13 pag-aaral
- Nebraska4 pag-aaral
- New Jersey8 pag-aaral
- New York27 pag-aaral
- North Carolina13 pag-aaral
- Ohio21 pag-aaral
- Oregon3 pag-aaral
- Pennsylvania15 pag-aaral
- Tennessee18 pag-aaral
- Texas36 pag-aaral
- Utah6 pag-aaral
- Virginia7 pag-aaral
- Wisconsin4 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07049848Safety and Feasibility of Intraoperative Visualization With Cytalux in Children
Nagre-recruitPhase 1
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06235125Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06444880BostonGene and Exigent Genomic INsight Study
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06272864Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
Nagre-recruitPhase 1/2
Edad 2 hanggang 30 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT05734066Anti-GD2 ADC M3554 in Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT06641908cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05366881Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma
Nagre-recruitPhase 2
Edad 8 hanggang 30 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05726383Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05711615Distance-Based Exercise to Preserve Function and Prevent Disability
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07059884A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06760819T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.
Nagre-recruitPhase 1
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06474676Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
Nagre-recruitPhase 1
Edad 3 hanggang 35 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT02390752Pilot Study of TumorGlow for Intraoperative Molecular Imaging of Sarcoma Metastases to the Lungs in Pediatric Patients
Nagre-recruitMaagang Phase 1
Edad 12 hanggang 17 · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07658768Activation Sarcoma: PROMIS and Mobility Evaluation in Sarcoma Patients
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07227961Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT0728373118F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
Nagre-recruitPhase 2
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06503146Lead-212 PSV359 Therapy for Patients With Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT06710756A Study of MGC026 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT06242470A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06942442STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT06975293A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT07705334Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT06498648LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy and Spectroscopy-based Molecular Urinalysis in Sarcoma Patients
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT06958107PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study
Nagre-recruitPhase 2
Edad 18 hanggang 39 · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT07874828Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.